Neuroendocrine Neoplasms of the Gynecologic Tract.
FIGO classification
PET/CT
cervical neuroendocrine tumor
gynecological NENs
imaging of neuroendocrine tumors
neuroendocrine
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
06 Apr 2022
06 Apr 2022
Historique:
received:
06
03
2022
revised:
01
04
2022
accepted:
01
04
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
Gynecological tract neuroendocrine neoplasms (NEN) are rare, aggressive tumors from endocrine cells derived from the neuroectoderm, neural crest, and endoderm. The primary gynecologic NENs constitute 2% of gynecologic malignancies, and the cervix is the most common site of NEN in the gynecologic tract. The updated WHO classification of gynecologic NEN is based on the Ki-67 index, mitotic index, and tumor characteristics such as necrosis, and brings more uniformity in the terminology of NENs like other disease sites. Imaging plays a crucial role in the staging, triaging, restaging, and surveillance of NENs. The expression of the somatostatin receptors on the surface of neuroendocrine cells forms the basis of increasing evaluation with functional imaging modalities using traditional and new tracers, including
Identifiants
pubmed: 35406607
pii: cancers14071835
doi: 10.3390/cancers14071835
pmc: PMC8998008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Gynecol Oncol. 2001 Apr;81(1):82-7
pubmed: 11277655
Lancet Oncol. 2015 Sep;16(9):e435-e446
pubmed: 26370353
J Clin Oncol. 2003 Sep 15;21(18):3495-501
pubmed: 12972526
Case Rep Obstet Gynecol. 2013;2013:827037
pubmed: 23878751
Clin Imaging. 2020 Mar;60(1):53-61
pubmed: 31864201
AJR Am J Roentgenol. 2018 Aug;211(2):267-277
pubmed: 29975116
Int J Mol Sci. 2019 Sep 23;20(19):
pubmed: 31547532
Crit Rev Oncol Hematol. 2021 Jun;162:103344
pubmed: 33933568
Abdom Radiol (NY). 2021 Jun;46(6):2323-2349
pubmed: 33175199
Obstet Gynecol Sci. 2016 Mar;59(2):116-22
pubmed: 27004202
Cancer Med. 2020 Sep;9(18):6524-6532
pubmed: 32705800
Neoplasia. 2017 Dec;19(12):991-1002
pubmed: 29091800
Oncotarget. 2020 Oct 06;11(40):3675-3686
pubmed: 33088427
Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):59-77
pubmed: 26971844
Gynecol Oncol. 2018 Feb;148(2):422-429
pubmed: 29248196
Int J Gynecol Cancer. 2019 Jul;29(6):986-995
pubmed: 31263021
BMC Cancer. 2018 May 4;18(1):530
pubmed: 29728073
Gynecol Oncol. 2019 Nov;155(2):254-261
pubmed: 31519319
Gynecol Oncol. 2014 Aug;134(2):410-8
pubmed: 24875120
Gynecol Oncol. 2016 Dec;143(3):552-557
pubmed: 27645621
Eur J Cancer. 2012 Jul;48(10):1484-94
pubmed: 22244826
Mod Pathol. 2018 Dec;31(12):1770-1786
pubmed: 30140036
J Belg Soc Radiol. 2020 Jan 23;104(1):4
pubmed: 31998862
Medicina (Kaunas). 2021 Dec 07;57(12):
pubmed: 34946283
PeerJ. 2021 Jul 6;9:e11563
pubmed: 34268005
Acta Radiol. 2014 May;55(4):389-98
pubmed: 23928010
Br J Dermatol. 2011 Nov;165(5):1147-8
pubmed: 21668427
PLoS One. 2012;7(3):e33762
pubmed: 22438992
Rare Tumors. 2011 Oct 21;3(4):e41
pubmed: 22355496
J Nucl Med. 2015 Jun;56(6):847-54
pubmed: 25952736
Expert Opin Biol Ther. 2016 Aug;16(8):989-1004
pubmed: 27070175
Gynecol Oncol. 2003 Mar;88(3):451-5
pubmed: 12648603
J Ovarian Res. 2019 Jul 25;12(1):69
pubmed: 31345245
Obstet Gynecol. 2008 Jun;111(6):1394-402
pubmed: 18515524
Endocr Relat Cancer. 2020 Jun;27(6):R211-R218
pubmed: 32276263
Radiol Clin North Am. 2020 Nov;58(6):1147-1159
pubmed: 33040854
Papillomavirus Res. 2018 Jun;5:134-142
pubmed: 29555602
Gynecol Oncol. 2017 Dec;147(3):589-596
pubmed: 28954697
PLoS One. 2012;7(4):e33674
pubmed: 22529895
Drugs. 2019 Jan;79(1):21-42
pubmed: 30560479
Clin Nucl Med. 2017 Mar;42(3):216-217
pubmed: 28005640
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):2004-10
pubmed: 20596866
Lancet. 1963 Feb 2;1(7275):238-9
pubmed: 14000847
Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S102-8
pubmed: 25341572
Gynecol Oncol. 2021 Jul;162(1):210-219
pubmed: 34023130
Curr Oncol Rep. 2017 Sep;19(9):59
pubmed: 28735441
Gynecol Oncol. 2016 Jun;141(3):588-591
pubmed: 27079212
Abdom Radiol (NY). 2018 Dec;43(12):3468-3478
pubmed: 29974177
Lancet Oncol. 2010 Jul;11(7):685-93
pubmed: 20362508
Arch Pathol Lab Med. 2004 Aug;128(8):857-62
pubmed: 15270619
Neuroendocrinology. 2017;104(3):209-222
pubmed: 27082107
Br J Cancer. 1998 Oct;78(8):1102-7
pubmed: 9792158
J Nucl Med. 2018 Jan;59(1):66-74
pubmed: 29025982
Oncol Lett. 2012 Jan;3(1):125-130
pubmed: 22740867
J Exp Clin Cancer Res. 2000 Sep;19(3):271-80
pubmed: 11144518
Obstet Gynecol. 1988 Jan;71(1):10-4
pubmed: 2827080
Pathol Res Pract. 2020 Jun;216(6):152993
pubmed: 32381384
Abdom Radiol (NY). 2020 Oct 23;:
pubmed: 33095312
Turk Patoloji Derg. 2015;31 Suppl 1:128-44
pubmed: 26177323
Gynecol Oncol. 2018 Jan;148(1):139-146
pubmed: 29113721
Int J Gynecol Cancer. 2015 Sep;25(7):1315-21
pubmed: 26186071
Radiol Clin North Am. 2011 May;49(3):529-48, vii
pubmed: 21569909
BMC Cancer. 2021 Sep 23;21(1):1046
pubmed: 34556082
Int J Gynecol Pathol. 2021 Sep 27;:
pubmed: 34570015
Mol Oncol. 2022 Feb;16(4):833-845
pubmed: 33830625
Int J Gynecol Cancer. 2020 Sep;30(9):1303-1307
pubmed: 32727929
Ann Oncol. 2008 Feb;19(2):321-6
pubmed: 17962205
Cancer Med. 2016 Jun;5(6):1108-15
pubmed: 26990881
J Formos Med Assoc. 1994 Jan;93(1):81-3
pubmed: 7915589
BMJ Case Rep. 2019 Mar 9;12(3):
pubmed: 30852510
Visc Med. 2017 Oct;33(5):324-330
pubmed: 29177160
Cancers (Basel). 2019 Aug 04;11(8):
pubmed: 31382663
Radiol Clin North Am. 2020 Nov;58(6):1161-1171
pubmed: 33040855
Case Rep Oncol Med. 2018 Feb 04;2018:9157036
pubmed: 29535879
Cancer Manag Res. 2020 May 14;12:3445-3456
pubmed: 32523375
Int J Gynecol Cancer. 2014 Feb;24(2):272-9
pubmed: 24401981
Am J Surg Pathol. 2010 Apr;34(4):525-32
pubmed: 20182342
Am J Surg Pathol. 2018 Jun;42(6):750-760
pubmed: 29505425
Am J Surg Pathol. 2021 Feb 1;45(2):147-159
pubmed: 33264139
Gynecol Oncol. 2018 May;149(2):420-427
pubmed: 29458976
Am J Dermatopathol. 2006 Apr;28(2):99-104
pubmed: 16625069
Abdom Radiol (NY). 2017 May;42(5):1472-1484
pubmed: 27942847
Cancer Med. 2021 Dec;10(23):8558-8569
pubmed: 34773393
Gynecol Oncol. 2017 Mar;144(3):637-646
pubmed: 28057354
J Clin Oncol. 2007 May 20;25(15):1967-73
pubmed: 17513802
Neuroendocrinology. 2014;100(4):265-77
pubmed: 25300695
Nat Rev Endocrinol. 2018 Nov;14(11):656-669
pubmed: 30158549
Gynecol Oncol. 2019 Dec;155(3):444-451
pubmed: 31635755
Gynecol Oncol. 2020 Sep;158(3):531-537
pubmed: 32641238
Cancer. 2003 Feb 1;97(3):568-74
pubmed: 12548598
Gynecol Oncol. 2001 Jul;82(1):32-9
pubmed: 11426959
Gynecol Oncol. 2004 Apr;93(1):27-33
pubmed: 15047210
Neuroendocrinology. 2019;109(2):83-99
pubmed: 30699437
Mol Oncol. 2021 Dec;15(12):3545-3558
pubmed: 34245124
Int J Clin Exp Pathol. 2021 Sep 15;14(9):1000-1009
pubmed: 34646419
Oncotarget. 2017 Jan 31;8(5):8095-8104
pubmed: 28042953
JAMA Oncol. 2017 Oct 01;3(10):1335-1342
pubmed: 28448665
Cancer Lett. 2021 Jan 1;496:104-116
pubmed: 33038491
J Comput Assist Tomogr. 2019 Nov/Dec;43(6):825-834
pubmed: 31453978
Gynecol Oncol. 2011 Jul;122(1):190-8
pubmed: 21621706
Insights Imaging. 2015 Feb;6(1):43-52
pubmed: 25592289
Int J Endocr Oncol. 2018 Feb 02;5(1):IJE04
pubmed: 30112163
Cancer Manag Res. 2021 Jun 08;13:4529-4540
pubmed: 34135630
Adv Anat Pathol. 2011 Nov;18(6):415-37
pubmed: 21993268
Am J Surg Pathol. 2007 May;31(5):774-82
pubmed: 17460463
Am J Obstet Gynecol. 2010 Oct;203(4):347.e1-6
pubmed: 20579961
Gynecol Oncol. 2017 Feb;144(2):384-390
pubmed: 27908529
Am J Obstet Gynecol. 2019 Jul;221(1):53.e1-53.e6
pubmed: 30849352
PLoS One. 2020 Jun 16;15(6):e0234505
pubmed: 32544169
Eur Radiol. 2016 Dec;26(12):4293-4302
pubmed: 26995208
Int J Gynecol Pathol. 1984;3(1):51-70
pubmed: 6145674